AM GROUP (01849): Will complete the audit procedures for the full-year performance of 2024 as soon as possible, the trading will resume on September 25th.
SinoMab BioScience Limited (01849) announced that the delay in the publication of the full-year results for 2024 may be due to the auditor's investigation.
AM GROUP (01849) announced that the delayed release of the full-year financial results for 2024 may be due to restrictions faced by the auditors in accessing the books and records of the Company's subsidiaries in the People's Republic of China. The Company has been working closely with the subsidiaries and auditors to provide all necessary information and documents to expedite the audit process for the full-year financial results of 2024.
In addition, the Company has applied to the Stock Exchange for the resumption of trading in its shares from 9:00 am on Wednesday, September 25, 2024.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


